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N-methyl-D-aspartate glutamate receptors (NMDARs) play a pivotal role in neural
development and synaptic plasticity, as well as in neurological disease. Since NMDARs
exert their function at the cell surface, their density in the plasma membrane is
finely tuned by a plethora of molecules that regulate their production, trafficking,
docking and internalization in response to external stimuli. In addition to transcriptional
regulation, the density of NMDARs is also influenced by post-translational mechanisms like
phosphorylation, a modification that also affects their biophysical properties. We previously
described the increased surface expression of GluN1/GluN2A receptors in transgenic
mice overexpressing the Dual specificity tyrosine-phosphorylation-regulated kinase 1A
(DYRK1A), suggesting that DYRK1A regulates NMDARs. Here we have further investigated
whether the density and activity of NMDARs were modulated by DYRK1A phosphorylation.
Accordingly, we show that endogenous DYRK1A is recruited to GluN2A-containing
NMDARs in the adult mouse brain, and we identify a DYRK1A phosphorylation site
at Ser1048 of GluN2A, within its intracellular C-terminal domain. Mechanistically, the
DYRK1A-dependent phosphorylation of GluN2A at Ser1048 hinders the internalization of
GluN1/GluN2A, causing an increase of surface GluN1/GluN2A in heterologous systems,
as well as in primary cortical neurons. Furthermore, GluN2A phosphorylation at Ser1048
increases the current density and potentiates the gating of GluN1/GluN2A receptors. We
conclude that DYRK1A is a direct regulator of NMDA receptors and we propose a novel
mechanism for the control of NMDAR activity in neurons.
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INTRODUCTION
N-methyl-D-aspartate receptors (NMDARs) belong to the
ionotropic class of glutamate receptors, playing critical roles in
neural development and survival, as well as in synaptic plasticity
and memory processes (Traynelis et al., 2010; Hunt and Castillo,
2012; Paoletti et al., 2013). Moreover, impairment of NMDAR
activity has been associated with certain pathological conditions
(reviewed in Lau and Zukin, 2007). N-methyl-D-aspartate recep-
tors are heterotetramers composed of two obligatory GluN1 sub-
units and two GluN2 (A–D) or GluN3 (A–B) subunits (Paoletti
et al., 2013). The biosynthetic pathway of NMDARs leads them to
the plasma membrane, where they act as cation-permeable chan-
nels gated simultaneously by co-agonists binding and membrane
depolarization (reviewed in Traynelis et al., 2010). N-methyl-
D-aspartate receptor activity is dictated by their location and
density at the cell surface, their GluN2 subunit composition,
and their post-translational modifications (Barria and Malinow,
2002; Lavezzari et al., 2004; Chen and Roche, 2007; Storey et al.,
2011). Non-genomic mechanisms are particularly important in
regulating the assembly, trafficking, docking and internaliza-
tion of NMDARs. Of these, the phosphorylation status of the
C-terminal domain of NMDARs regulates activity-dependent
NMDAR levels and activity (Salter and Kalia, 2004; Chen and
Roche, 2007; Sanz-Clemente et al., 2012). A number of kinases
may preferentially phosphorylate a given GluN2 subunit isoform,
linking NMDAR composition and activity to intracellular sig-
naling (Sanz-Clemente et al., 2012; Ryan et al., 2013). However,
the complete picture of NMDAR phosphorylation, including the
kinases and amino acid residues involved, and the functional
output of phosphorylation events, is still to be fully defined.
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We previously revealed a link between the Dual specificity
tyrosine-phosphorylation-regulated kinase 1A (DYRK1A) and
NMDARs, evident through the increased GluN1/GluN2A con-
tent of synaptosomes obtained from transgenic TgDyrk1A mice
(Altafaj et al., 2008). Dual specificity tyrosine-phosphorylation-
regulated kinase 1A is a protein kinase found in both the nucleus
and cytosol of many different cell types. Upon self-activation by
tyrosine autophosphorylation, this kinase phosphorylates serine
and threonine residues in exogenous substrates that are involved
in a wide variety of cellular functions, including intracellular sig-
naling and synaptic remodeling (reviewed in Aranda et al., 2011).
Dual specificity tyrosine-phosphorylation-regulated kinase 1A
has received a lot of attention because of its cytogenetic location in
the Down syndrome (DS) critical region on human chromosome
21 (HSA21) and its overexpression in DS individuals (Guimerà
et al., 1996). Consistent with its potentially etiological role in
DS, Dyrk1A overexpression in mice provokes DS-like neurode-
velopmental, visual, motor and cognitive phenotypic alterations
(reviewed in Park and Chung, 2013), some of which can be
rescued through Dyrk1A normalization (Ortiz-Abalia et al., 2008;
Altafaj et al., 2013; Laguna et al., 2013).
Here we show that DYRK1A interacts functionally with
GluN2A to post-translationally regulate the biophysical prop-
erties and the surface expression of NMDARs. We found
that DYRK1A physically interacts with GluN1/GluN2A com-
plexes and that it phosphorylates the C-terminal domain of
the GluN2A subunit at serine residue 1048 (S1048). DYRK1A-
mediated phosphorylation of this residue hinders the internaliza-
tion of GluN1/GluN2A receptors, provoking increased cell surface
expression of these receptors. Moreover, GluN2A S1048 phospho-
rylation not only increases the peak current density but also the
GluN1/GluN2A channel opening rate. Together, these findings
suggest that DYRK1A is a novel regulator of GluN1/GluN2A
receptors.
MATERIALS AND METHODS
PLASMIDS
The expression plasmids for rat GluN1 and GFP-GluN2A were
kindly provided by Dr. Vicini (Georgetown University Medi-
cal Center, Washington, USA; Vicini et al., 1998). The plas-
mids to express HA-tagged rat GluN1 in mammalian cells and
for the bacterial expression of rat GluN2A C-terminal domain
fragments (C1: 897–1117, C2: 1102–1409 and C3: 1409–1464)
fused at the N-terminal to glutathione S-transferase (GST) were
kindly provided by Dr. Nakanishi and Dr. Nakazawa, respec-
tively (Institute of Medical Science, University of Tokyo, Japan;
Tezuka et al., 1999; Taniguchi et al., 2009). The rat GluN2A C-
terminal domain fragments (C-term: 897–1464, C1∆1: 839–1076,
C1∆2: 839–1016) were digested with EcoRI/XhoI and ligated
into the digested pGEX-5X-2 vector (Promega). Nucleotide
changes (the mutation of serine codons to alanine) were achieved
by oligonucleotide-directed mutagenesis, using the QuikChange
site-directed mutagenesis kit according to the manufacturer’s
instructions (Stratagene). All the plasmids generated by PCR or
site-directed mutagenesis, as well as all the in-frame fusions,
were verified by DNA sequencing. The expression plasmids
encoding the human DYRK1A variants, both the wild type
and the kinase-inactive (KD) mutant, have been described
previously: HA-tagged variants (pHA derivatives), N-terminal
GST fusions (pGST derivatives), and DYRK1A fused to the
enhanced green fluorescent protein (described in Alvarez et al.,
2007).
GST FUSION PROTEIN EXPRESSION IN BACTERIA
Expression constructs for GST fusion proteins were transformed
into Escherichia coli BL21(DE3)pLysS and protein expression
was induced with 0.1 mM isopropyl-β-D-thiogalactopyranoside
for either 3 h at 37◦C for the unfused GST, GST-C1, GST-C2
and GST-C3 fusion proteins, or for 8 h at 20◦C for GST-
CterGluN2A and GST-DYRK1A. The recombinant proteins were
bound to glutathione beads (GE Healthcare Life Sciences) and
when required, they were eluted with 10 mM reduced glutathione
in 50 mM Tris-HCl [pH 8], and dialyzed against a buffer con-
taining 50 mM HEPES [pH 7.4], 150 mM NaCl and 2 mM
EDTA. Protein concentrations were determined with a colorimet-
ric assay (the bicinchoninic acid protein assay kit, BCA: Pierce)
and/or by Coomassie blue staining of sodium dodecyl sulfate
(SDS)-polyacrylamide gels in which they were compared with
standards.
IMMUNOPRECIPITATION
For immunoprecipitation of the endogenous GluN1 and
DYRK1A complexes, brains from 2- to 4-month-old mice were
dissected out and mechanically homogenized with 10 up-and-
down strokes at 700 rpm of a glass-Teflon homogenizer in 10
vol of cold sucrose buffer (320 mM sucrose, 10 mM HEPES [pH
7.4], 1 mM EDTA and Halt™ Protease and Phosphatase Inhibitor
Cocktail [PPIC; Pierce]). The homogenate was centrifuged at
4◦C for 10 min at 800×g to remove the nuclei and large debris.
Subsequently, the supernatant was centrifuged for 15 min at
14,000×g to obtain the membrane-associated fraction, which
was further solubilized in lysis buffer (10 mM HEPES [pH 7.4],
150 mM NaCl, 1 mM EDTA, 0.1 mM MgCl2, 1% Nonidet P40
[NP-40]) for immunoprecipitation with anti-DYRK1A and RIPA
buffer for immunoprecipitation with anti-GluN1 supplemented
with PPIC. The homogenates were clarified by centrifugation
at 4◦C for 10 min at 16,000×g. After preclearing the soluble
lysates for 1 h at 4◦C with equilibrated protein G-Sepharose,
they were incubated overnight at 4◦C with 10 µg of either an
anti-GluN1 mouse monoclonal antibody (mAb; Millipore Cat#
05-432 RRID:AB−10015247), or an anti-DYRK1A mAb (Abnova
Corporation Cat# H00001859-M01 RRID:AB−534844). Non-
specific mouse immunoglobulin G (IgG; Sigma-Aldrich Cat#
I5381 RRID:AB−1163670) was used as a control for specificity.
The immunocomplexes were incubated with protein G-Sepharose
for 2 h at 4◦C, and the beads were then washed twice with lysis
buffer and once with phosphate-buffered saline (PBS). The bound
proteins were eluted in Laemmli’s buffer (LB) and analyzed in
Western blots.
WESTERN BLOT ANALYSIS
For protein extraction, cells were washed with PBS and scraped
off the plate in 400 µl of lysis buffer (50 mM HEPES [pH
7.4], 150 mM NaCl, 2 mM EDTA, 1% NP-40 and PPIC).
Frontiers in Cellular Neuroscience www.frontiersin.org October 2014 | Volume 8 | Article 331 | 2
Grau et al. Regulation of GluN1/GluN2A by DYRK1A
After 10 min incubation at 4◦C, the cell debris was pelleted at
15,000×g, the solubilized proteins were collected and the pro-
tein concentration was determined using a BCA assay. Proteins
were separated by 8% SDS-PAGE and transferred to nitrocel-
lulose membranes (Amersham), which were then blocked with
10% skimmed milk in 10 mM Tris-HCl (pH 7.5)/100 mM
NaCl (TBS) plus 0.1% Tween 20 (TBS-T). The membranes
were probed overnight at 4◦C with the primary Ab of inter-
est (diluted in TBS-T/ + 5% skimmed milk) directed against:
GluN1, GluN2A (Sigma-Aldrich Cat# M264 RRID:AB−260485),
DYRK1A, the HA epitope (Covance, Inc. Cat# MMS-101R-500
RRID:AB−10063630), and GFP (Clontech Cat# 632381). Pro-
tein loading was monitored by assessing β-Actin (Sigma-Aldrich
Cat# A2228 RRID:AB−476697). Antibody binding was detected
with an anti-mouse or anti-rabbit Ab coupled to horseradish
peroxidase (Dako, Cat. No. P0447 and P0448, respectively) for
1 h at room temperature (RT) and the immunocomplexes were
visualized by chemiluminescence (ECL detection system: Pierce),
following the manufacturer’s instructions. Immunosignals were
analyzed densitometrically with Image J software (National Insti-
tutes of Health, USA).
IN VITRO KINASE ASSAYS
The in vitro kinase (IVK) assays were performed with either
GluN1 immunocomplexes from mouse brain or bacterially
expressed recombinant GST fusion proteins as the substrates, and
bacterially expressed GST-DYRK1A (wt or KD version) as the
kinase, purified as described previously (Alvarez et al., 2007). For
IVK assays with anti-GluN1 immunocomplexes, the immobilized
proteins were washed twice with kinase buffer (50 mM HEPES
[pH 7.4], 0.5 mM dithiothreitol, 5 mM MgCl2, 5 mM MnCl2),
and incubated for 20 min at 30◦C in 30 µl of kinase buffer
with a final concentration of 50 µM ATP and [γ-32P]ATP (1 ×
10−2 µCi/pmol). For GST fusion proteins, eluted GST-GluN2A
C-terminal fragments (0.5–1 µg) were incubated for 20 min at
30◦C in 40 µl of kinase buffer with 50 µM ATP and [γ-32P]ATP
(1 × 10−3 µCi/pmol). Reactions were stopped by adding 6×
LB, the samples were resolved by SDS-PAGE and then stained
with Coomassie blue. The incorporation of 32P was detected by
autoradiography of the dried gels.
CELL CULTURE AND TRANSFECTION
HEK-293T and COS-7 cell lines were obtained from the American
Type Culture Collection and maintained at 37◦C in Dulbecco’s
modified Eagle’s medium (DMEM), supplemented with 10% fetal
calf serum, antibiotics (100 units/ml penicillin and 100 µg/ml
streptomycin). Furthermore, D-2-amino-5-phosphonopentanoic
acid (D-AP5, 200 µM for HEK-293T and 500 µM for COS-7:
Abcam Biochemicals) was added to the medium to avoid exci-
totoxicity in cells co-transfected with GluN1 and GFP-GluN2A
(1:1 ratio). Transient transfection of HEK-293T cells was achieved
by the calcium phosphate method and the cells were analyzed
48 h after transfection. COS-7 cells were transiently transfected
with Lipofectamine 2000 (Life Technologies), according to the
manufacturer’s recommendations, and the cells were fixed 20 h
after transfection.
To prepare dissociated cortical neuron cultures, embry-
onic day (E)18 mouse embryos were obtained from pregnant
females, the cerebral cortex was isolated and maintained in
cold Hank’s Balanced Salt Solution (HBSS, Gibco) supplemented
with 0.45% glucose (HBSS-Glucose). After carefully remov-
ing the meninges, the cortical tissue was digested mildly with
trypsin for 17 min at 37◦C and dissociated. The cells were
washed three times in HBSS and resuspended in Neurobasal
medium supplemented with 2 mM Glutamax (Gibco) before
filtering in 70 µm mesh filters (BD Falcon). The cells were
then plated onto glass coverslips (5 × 104 cells/cm2) coated
with 0.1 mg/ml poly-L-lysine (Sigma) and 2 h after seeding, the
plating medium was substituted by complete growth medium,
Neurobasal medium supplemented with 2% B27 (Invitrogen)
and 2 mM Glutamax, and the coverslips were incubated at
37◦C in a humidified 5% CO2 atmosphere. Every 3–4 days,
half of the conditioned medium was removed and replaced
by fresh growth medium. Primary cultures were transfected
with Lipofectamine 2000 on day 8 in vitro (div8), according
to the manufacturer’s, instructions and the cells were fixed
48 h after transfection. All the experimental procedures were
carried out according to European Union guidelines (Directive
2010/63/EU) and following protocols that were approved by the
Ethics Committee of the Bellvitge Biomedical Research Institute
(IDIBELL).
IMMUNOFLUORESCENCE ANALYSIS OF SURFACE NMDA RECEPTORS
The surface-to-total expression of NMDARs was analyzed in
COS-7 cells that were washed twice with PBS before they
were fixed with 4% paraformaldehyde (PFA). Surface expression
of GFP-GluN2A was detected using an antibody against GFP
(1:1000, Life Technologies Cat# A11122 RRID:AB−10073917)
that recognizes the extracellular epitope of heterologously
expressed receptors and that was visualized with an Alexa
647-conjugated goat anti-rabbit Ab (1:1000, Molecular Probes
(Invitrogen) Cat# A21245 RRID:AB−141775). The total pool
of receptors was detected by the fluorescent signal emitted by
the GFP-GluN2A transfected. HA-DYRK1A positive cells were
identified after permeabilizing the cells with 0.1% Triton X-100
and labeling with anti-HA (1:1000) that was visualized with an
Alexa 555-conjugated donkey anti-mouse Ab (1:2000, Molecular
Probes, Cat# A31570).
To analyze the surface expression of the transfected
NMDARs in primary neuronal cultures, cells were washed
twice with PBS and fixed with 4% PFA in PBS containing
4% sucrose. The surface expression of GFP-GluN2A was
detected with anti-GFP (1 h) and visualized with an Alexa
488-conjugated goat anti-rabbit Ab (1:1000, Life Technologies
Cat# A11034 RRID:AB−10562715). The intracellular pool of
receptors was identified by permeabilizing cells with 0.1%
Triton X-100 and labeling them with a rabbit anti-GFP-
Alexa 555-conjugated Ab (1:250, Invitrogen Cat# A31851
RRID:AB−1500154). HA-DYRK1A positive neurons were
identified by labeling them with mouse anti-HA that was
visualized with an Alexa 647-conjugated donkey anti-mouse
Ab (1:1000, Molecular Probes (Invitrogen) Cat# A31571
RRID:AB−162542).
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Fluorescence was visualized with a Leica TCS-SL spectral con-
focal microscope (Leica Microsystems, Wetzlar, Germany) using
a Plan-Apochromat 63×/1.4 N.A. immersion oil objective (Leica
Microsystems) and a pinhole aperture of 114.54 µm or 202 µm
(for surface receptors). To excite the different fluorophores, the
confocal system is equipped with three excitation laser beams at
488 nm, 546 nm and 633 nm. In each experiment, the fluorescence
intensity was measured in 10–15 cells per condition (COS-7)
and in 10–15 dendrites from at least two or three pyramidal
neurons per condition. Fluorescence was quantified using Adobe
Photoshop CS5 software (Adobe Systems Inc.) and the results are
represented as the mean ± standard errors of the means (SEM)
of the ratio of surface/total (COS-7 cells) or surface/intracellular
(primary cultures) GluN2A immunosignal, analyzing at least
three independent experiments.
ENDOCYTOSIS ASSAYS
N-methyl-D-aspartate glutamate receptor internalization was
assessed using an “antibody feeding” technique in living COS-7
cells that expressed wild-type or mutant NMDARs (transiently
co-transfected with GluN1 and GFP-tagged GluN2A constructs),
both in the presence or absence of transfected HA-DYRK1A.
To measure the rate of NMDAR internalization, cells were
labeled for 30 min at 4◦C with rabbit anti-GFP Ab (1:1000),
which binds to the GFP tag of membrane-anchored GFP-
GluN2A/GluN1 receptors. The medium containing the anti-
body was removed, the cells were washed and they were
incubated for 30 min at 37◦C to allow NMDAR internal-
ization. The cells were then washed twice with PBS, fixed
with 4% PFA/2% sucrose and washed three times with
PBS. After blocking, surface NMDARs were labeled with an
anti-rabbit Alexa 647-conjugated secondary Ab (1:500) and
following washing of the secondary Ab, the cells were per-
meabilized and the internalized NMDARs were labeled with
an Alexa 555-conjugated anti-rabbit Ab (1:4000, Molecular
Probes (Invitrogen) Cat# A21429 RRID:AB−141761). Cells co-
transfected with HA-DYRK1A were also labeled with anti-HA
(1:1000) that was visualized with an Alexa 488-conjugated anti-
mouse secondary Ab (1:1000, Life Technologies Cat# A21202
RRID:AB−10049285). The cells immunofluorescence was then
analyzed as described above and the results are represented as
the mean ± SEM of the ratio of internalized/surface GluN2A
subunits.
ELECTROPHYSIOLOGICAL RECORDINGS OF WHOLE-CELL NMDA
CURRENTS IN HEK293T CELLS
Electrophysiological recordings were obtained 24 h after trans-
fection, perfusing the cells continuously at RT with the external
bath solution (in mM): 145 NaCl, 5 KCl, 1 CaCl2, 11 glucose,
and 10 HEPES, adjusted to pH 7.3 with Tris and supplemented
with the open-channel non-reversible antagonist MK-801 (5 µM,
Tocris). N-methyl-D-aspartate (1 mM, Tocris), in the presence
of glycine (50 µM, Tocris) and MK-801 (5 µm), was applied
for 3 s using a fast perfusion system (VC38 Focal Perfusion Sys-
tem, ALA Scientific Instruments). Such system features solenoid
valves and a Quartz MicroManifold (QMM) that are optimized
for high-speed solution exchange, with valve opening speeds of
1–2 ms. The activated currents were recorded in the whole-
cell mode at a holding potential of −60 mV, acquired at 10
kHz and filtered at 1 kHz. Electrodes with open-tip resis-
tances of 2–5 MΩ were used, and the data were acquired and
analyzed using pClamp 8 software (Axon Instruments) and a
D-6100 Darmstadt amplifier (List Medical, Germany). The inter-
nal pipette solution contained (in mM): 140 CsCl, 1 EGTA, 4
Na2ATP, 0.1 Na3GTP and 10 HEPES, adjusted to pH 7.25 with
CsOH.
Statistical analysis
Comparison between experimental groups was evaluated using
InStat Software (GraphPad Software, Inc.), applying an One Way
Analysis of Variance (ANOVA) followed by a Bonferroni post hoc
test or a Student’s t test. Data are presented as the means ± SEM,
at least, three independent experiments.
RESULTS
DYRK1A INTERACTS WITH GluN2A AND PHOSPHORYLATES ITS
CYTOSOLIC DOMAIN AT SERINE 1048
Having previously established a functional connection between
the GluN2A NMDAR subunit and the protein kinase DYRK1A
in animal models of overexpression (Altafaj et al., 2008), we
evaluated the possibility that DYRK1A had a direct effect on
GluN2A-containing NMDARs. The ability of a kinase to phos-
phorylate its substrate requires a physical interaction—even if
it is indirect, weak and/or transient—between the enzyme and
its potential substrate (GluN1/GluN2A). To test this possibil-
ity, and given that a fraction of DYRK1A is present in non-
nuclear lysates of the mouse brain (Martí et al., 2003; Aranda
et al., 2008), as are NMDARs, we assessed the proteins that
associate with this kinase by immunoprecipitating it from adult
mouse brain lysates with an antibody that specifically recognizes
DYRK1A. In Western blots, a GluN2A-immunoreactive protein
was eluted from the beads that pulled down DYRK1A but not
from the non-specific IgG control beads (Figure 1A), indicating
that GluN2A and DYRK1A were present in the same protein
complexes.
To assess whether NMDAR subunits are substrates of the
DYRK1A serine/threonine kinase, complexes containing the
GluN1 subunit were immunopurified from adult mouse brain
lysates. These complexes contained both GluN1 and GluN2A, as
witnessed in Western blots (Figure 1B, left panel), and they were
used as substrate in the IVK assay with purified GST-DYRK1A.
Weak phosphorylation of two protein bands with molecular
weights around 170 kDa and 130 kDa was evident when the IVK
was performed in the presence of GST alone (Figure 1B). Based
on the electrophoretic mobility of the NMDAR subunits, these
labeled bands could correspond to GluN2A (165 kDa) and GluN1
(115 kDa), suggesting that the NMDAR complexes were able
to recruit endogenous kinases. However, radiolabeled ATP was
incorporated more intensely into these proteins when purified
DYRK1A was included in the IVK assay (Figure 1B), an indication
that both subunits are targets of DYRK1A. While the assignment
of GluN2A phosphorylation was clear, we could not be com-
pletely confident about the phosphorylation of GluN1, since the
molecular weight of the putative radilolabeled GluN1 has a similar
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FIGURE 1 | Dual specificity tyrosine-phosphorylation-regulated kinase
1A interacts with GluN2A and phosphorylates the GluN2A subunit at
S1048. (A) Solubilized proteins from the adult mouse brain (input lane; 10% of
lysates) were immunoprecipitated with either a mouse IgG or an anti-DYRK1A
antibody, and both the lysates and the immunoprecipitates were analyzed in
Western blots probed with anti-GluN2A and anti-DYRK1A antibodies as
indicated. (B) Equivalent aliquots of anti-GluN1 purified immunocomplexes
obtained from the adult mouse brain were analyzed in Western blots probed
with an anti-GluN2A antibody (left panel) or they were used as the substrate
in a radioactive in vitro phosphorylation assay in the presence or absence of
purified recombinant GST-DYRK1A. The radiolabeled proteins were then
fractionated by SDS-PAGE and detected by autoradiography (right panel). The
arrows indicate the phosphorylated GluN2A and possibly, the phosphorylated
GluN1, and the stars indicate the labeled bands resulting from GST-DYRK1A
autophosphorylation. (C) Schematic representation of the GluN2A subunit
topology and the GST fusion proteins covering the cytoplasmic tail of GluN2A
used in the assays. (D) As indicated, bacterially purified GluN2A GST-fusions
(Continued )
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FIGURE 1 | Continued
or unfused GST were examined in an IVK assay, in the presence of a GST
fusion protein of the wild-type (wt) or kinase-deficient DYRK1A (KD). The
substrates were analyzed by Coomassie staining (left panel) and the
phosphorylated bands indicated by black arrows represent the full-length
recombinant proteins, while the white arrows refer to the GluN2ACter
truncated products and the asterisks indicate the GST-DYRK1Awt
autophosphorylated bands (full-length or truncated products). (E) Schematic
representation of the different mutant variants of the GST-GluN2AC1
fragment in which the asterisks indicate the position of the corresponding
Ser to Ala mutants. (F) The GST-GluN2AC1 fragment or the indicated
mutants were used as substrates in IVK assays with GST-DYRK1A. The
panel shows a representative experiment and the histogram corresponds to
the average 32P incorporation ± SEM (n = 2–3) calculated by densitometry
(*p < 0.05). (G) The amino acid sequences of GluN2A from human
(NP−000824), mouse (NP−032196), rat (NP−036705), dog (XP−005621613),
sheep (XP−004020812) and chicken (XP−425252) were aligned to show the
conserved region surrounding S1048 (marked with an asterisk). The numbers
indicate the first and last amino acids listed.
electrophoretic mobility as autophosphorylated GST-DYRK1A
(Figure 1D).
The phosphorylation of the GluN2A subunit described
in the literature (Sanz-Clemente et al., 2012) and deposited
in the Phosphosite database1 occurs mostly in its intracel-
lular C-terminal domain. Therefore, to further confirm the
ability of DYRK1A to phosphorylate GluN2A, we focused
on the GluN2A region between amino acids 839 and 1464,
corresponding to its cytosolic tail. The GluN2A C-terminal
domain (Cter), and three different non-overlapping fragments
(C1, C2 and C3; Figure 1C), were expressed as GST fusion
proteins in bacteria (Figure 1D) and assayed as substrates
in IVKs with bacterially expressed GST-DYRK1A wild-type
or GST-DYRK1AKD, a kinase-deficient mutant as a negative
control. As expected, no phosphorylation of these substrates
was detected in the presence of GST-DYRK1AKD, confirm-
ing the incapacity of this mutant to autophosphorylate or to
phosphorylate exogenous substrates (Figure 1D). By contrast,
GST-DYRK1Awt was autophosphorylated in the IVK, as evi-
dent by the presence of the signals at 130 kDa (full-length
GST-DYRK1Awt), 36 kDa and 29 kDa (GST-DYRK1A trun-
cated products). In the case of the GluN2A cytoplasmic tail
(GluN2A-Cter), the complete fragment was phosphorylated in
the assay (Figure 1D), indicating the ability of DYRK1A to
phosphorylate the cytosolic domain of GluN2A. However, only
the GluN2A C1 fragment (897–1117) proved to be a DYRK1A
substrate, in contrast to the other truncated Cter fragments,
C2 and C3, (Figure 1D). The Cter region putatively phos-
phorylated by DYRK1A, was further narrowed down by gen-
erating two deletion mutants (GST-GluN2AC1∆1 [839–1076]
and GST-GluN2AC1∆2 [839–1016]; Figure 1E). Eliminating
residues 1076–1117 did not alter DYRK1A phosphorylation,
while the deletion of amino acids 1017–1076 completely abolished
DYRK1A-mediated phosphorylation of GluN2AC1 (Figure 1F),
suggesting that DYRK1A targets residues between amino acids
1017–1076 of GluN2A.
1http://www.phosphosite.org
Dual specificity tyrosine-phosphorylation-regulated kinase 1A
has been described as a proline-directed protein kinase, showing
preference for serine and threonine residues followed by a pro-
line, and with an arginine at position -3 (Himpel et al., 2000).
Close inspection of the GluN2A Cter suggested the presence
of a unique putative DYRK1A-phosphorylation site at serine
residue 1048 (S1048), which is conserved in GluN2A receptors
from several species (Figure 1G). Mutation of this serine residue
to the non-phosphorylatable amino acid alanine significantly
reduced DYRK1A-mediated phosphorylation. Such a reduction
was not observed when other serine residues within the GluN2A-
C1 fragment were mutated (S912, S913, S917, S1112; Figure 1F),
confirming the importance of S1048 for DYRK1A phosphoryla-
tion of GluN2A.
DYRK1A ENHANCES THE SURFACE EXPRESSION OF GluN1/GluN2A
RECEPTORS
Phosphorylation of NMDA receptors is a mechanism regulating
their trafficking and endocytosis, which in turn modulates their
surface density (Lin et al., 2006; Sanz-Clemente et al., 2010;
Zhang et al., 2012; Chowdhury et al., 2013). Thus, we hypoth-
esized that DYRK1A phosphorylation of GluN2A might regu-
late the surface expression of NMDARs. To test this hypothesis,
we first assessed the surface density of GluN2A in COS7 cells
exogenously expressing GluN1 and GFP-GluN2A alone (GluN1-
GluN2A), or in the presence of wild-type or KD HA-DYRK1A.
Immunofluorescence analysis showed a significant increase in
the surface:total ratio of GFP-GluN2A when DYRK1A was co-
expressed with this subunit (100 ± 3.7% for GluN1-GluN2A
cells vs. 126 ± 5.0% for DYRK1A-expressing cells; n = 130
and 111, respectively; p < 0.001; Figure 2). No such enhance-
ment was detected when the kinase inactive DYRK1AKD was
co-expressed with the NMDAR subunits (99 ± 4.6% for cells
co-expressing KD DYRK1AKD; n = 45; Figure 2). We then
generated GFP-fusions of GluN2A in which S1048 was mutated
to a non-phosphorylatable amino acid (Ser1048Ala) or to an
amino acid that mimics the phosphorylated status of this residue
(Ser1048Glu). The surface density of GFP-GluN2AS1048A showed
a surface:total ratio similar to wild type GluN2A (98 ± 6.5%;
n = 38; Figure 2) and moreover, DYRK1A failed to increase
the surface levels of the phospho-deficient GFP-GluN2AS1048A
(98 ± 6.5% for GluN1-GluN2AS1048A vs. 110 ± 6.8 for cells co-
expressing DYRK1A; n = 38 and 47, respectively). Conversely, the
surface:total ratio of the phospho-mimetic GFP-GluN2AS1048E
mutant was higher (100 ± 3.7 for control cells vs. 128 ± 6.8
for DYRK1A-expressing cells; n = 130 and 59, respectively;
p < 0.001), even in the absence of HA-DYRK1A (Figure 2).
The increase in the surface expression of GluN2AS1048E was
not enhanced by co-transfection of DYRK1A (128 ± 6.8 for
GluN1-GluN2AS1048E vs. 119 ± 6.9 for DYRK1A-expressing
cells; n = 59 and 52, respectively), suggesting that if other
potential GluN2A secondary phosphosites of DYRK1A existed,
they would not be involved in the increased GluN2A surface
expression.
To translate the observed cell surface enrichment of
GluN1/GluN2A in the presence of DYRK1A to a neuronal
context, we evaluated the surface density of transiently transfected
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FIGURE 2 | Dual specificity tyrosine-phosphorylation-regulated kinase
1A mediated phosphorylation of GluN2A at S1048 increases the
surface expression of GluN2A. COS-7 cells were transiently
co-transfected with plasmids to express GluN1 and wild-type (wt), or
mutant versions of GFP-GluN2A (S1048A, phospho-deficient; S1048E,
phospho-mimetic), in the presence or absence of HA-DYRK1A (wt,
wild-type; KD, kinase-inactive). After fixing, the cells were incubated
with an anti-GFP antibody to label the surface receptors (blue). Direct
green fluorescence was used to measure total GFP-GluN2A expression
(green). HA-DYRK1A expressing cells were identified by anti
HA-immunostaining (red). Scale bar = 10 µm. The histogram represents
the mean ± SEM of the GluN2A surface expression normalized to the
total GFP-GluN2A signal, with the values for transfections
GluN1+GFP-GluN2Awt considered as 100 (n = 38–130 cells from, at
least, three independent experiments per condition; *p < 0.05,
***p < 0.001, ANOVA).
GFP-GluN2A in primary cortical neurons established from
mouse embryos. In primary cortical neurons, the intracellular
levels of transfected GluN2A subunit was neither affected
by the presence of a mutation on Ser1048 (96.7 ± 10.0% of
control for GluN2AS1048A and 97.9 ± 5.7% for GluN2AS1048E;
n = 31–52) nor by the presence of HA-DYRK1A (110.5 ± 8.9%
of control; n = 48). As observed in COS7 cells, the presence
HA-DYRK1A increased the surface expression of GFP-GluN2A
in the dendrites of primary cortical neurons (surface:intracellular
GFP ratio = 116 ± 4% of control; n = 43–48, control or
DYRK1A transfected; p < 0.01) but not that of the phospho-
deficient GFP-GluN2AS1048A construct (106.4 ± 3.5% of
control; n = 31; Figure 3). Likewise, the phospho-mimetic
mutant GFP-GluN2AS1048E showed a robust increase in surface
expression compared with GFP-GluN2A (135.4 ± 2.7% of
control; n = 52; p < 0.001). Collectively, these results indicate
that S1048 phosphorylation is necessary and sufficient for
DYRK1A to increase the levels of GluN2A at the plasma
membrane.
DYRK1A REDUCES THE INTERNALIZATION OF SURFACE GluN1/GluN2A
HETERODIMERS
The density of NMDARs at the cell surface reflects the balance
between delivery/docking mechanisms (“on” mechanisms) and
receptor internalization (“off” mechanisms), processes critical
for synaptic maturation (Barria and Malinow, 2002). N-methyl-
D-aspartate glutamate receptors traffic between the plasma
membrane and intracellular compartments through vesicle-
mediated membrane delivery and endocytosis. Phosphorylation
of NMDARs regulates the clathrin-mediated endocytosis of these
receptors (Chung et al., 2004; Lavezzari et al., 2004; Scott et al.,
2004; Prybylowski et al., 2005; Sanz-Clemente et al., 2010;
Chowdhury et al., 2013), a mechanism that possibly explains the
increase in surface NMDAR expression provoked by DYRK1A.
Therefore, we performed antibody-feeding assays in living cells
to quantify the internalization rate of GFP-GluN2A in the pres-
ence or absence of DYRK1A. Unlike the kinase inactive ver-
sion, wild type HA-DYRK1A significantly decreased the relative
amount of GFP-GluN2A internalized compared with cells that
did not express DYRK1A (100 ± 4.2% for GluN1-GluN2A vs.
73 ± 4.5% for DYRK1Awt co-expressing cells [p < 0.001] or
94± 10.1% for cells co-expressing DYRK1AKD [non-significant];
n = 115, 97 and 33, respectively; Figure 4). By contrast, the
internalization of the phospho-deficient GluN2AS1048A was not
affected when co-expressed with DYRK1A (100± 7.2 for GluN1-
GluN2AS1048A cells vs. 90 ± 7.3 for DYRK1A-expressing cells;
n = 52 and 53, respectively). Furthermore, the rate of internal-
ization of the phospho-mimetic GluN2AS1048E mutant was also
significantly reduced, irrespective of the presence of DYRK1A (43
± 4.8% for cells expressing GluN1-GluN2AS1048E construct and
45 ± 6.7% for cells co-expressing DYRK1A and GluN2AS1048E;
n = 31 and 20, respectively; p < 0.001). Overall, these results
indicate that the phosphorylation of GluN2A at S1048 is critical
for DYRK1A to dampen NMDAR endocytosis. Moreover, the
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FIGURE 3 | Dual specificity tyrosine-phosphorylation-regulated kinase
1A mediated phosphorylation of GluN2A at S1048 increases its surface
expression in primary cortical neurons. Primary cultures of mouse
embryo cortices were transiently transfected with GFP-GluN2A (wt,
wild-type; S1048A, phospho-deficient mutant; S1048E, phospho-mimetic
mutant) on day in vitro 8 (DIV8), in the presence or absence of heterologous
HA-DYRK1A. The effect of DYRK1A on the surface:intracellular ratio of
GluN1/GluN2A in primary mouse cortical neurons was evaluated by
immunofluorescence. Prior to permeabilization,
(Continued )
FIGURE 3 | Continued
anti-GFP/Alexa488 was used to detect the surface chimeric receptors
(represented in green), whereas intracellular GFP-GluN2A receptors were
visualized after permeabilizing the cells, using an anti-GFP/Alexa555
antibody. Scale bar = 5 µm. The histogram represents the mean ± SEM
GluN2A surface expression normalized to the intracellular GFP-GluN2A
signal (n = 31–52 dendrites from, at least, three independent experiments
per condition, *p < 0.05, **p < 0.01, ***p < 0.001, ANOVA).
inhibitory effect on the rate of receptor internalization could
contribute to the observed increase in NMDAR surface density
in DYRK1A-expressing cells.
DYRK1A MODULATES GluN1/GluN2A-MEDIATED NMDA CURRENTS
In addition to the cellular consequences resulting from NMDAR
phosphorylation, this post-translational modification could also
potentially affect the biophysical properties of NMDARs. We
assessed the potential regulatory effects of GluN2A S1048 phos-
phorylation by DYRK1A by studying the electrophysiological
properties of NMDA elicited currents in HEK-293T cells exoge-
nously expressing the GluN1 and GluN2A subunits. Currents
elicited by NMDA were recorded in the whole-cell configuration
24 h after transfection, in the presence of the essentially irre-
versible NMDAR open-channel blocker MK-801. As the channel
must enter the open state to be blocked by MK-801, the decay time
constant of the current in the presence of both NMDA and MK-
801 can be used to determine the opening rate (Jahr, 1992; Rosen-
mund et al., 1995). In cells expressing GluN1/GluN2Awt, the peak
NMDA elicited whole-cell current density increased significantly
in the presence of DYRK1A (from 64.74± 16.43 pA/pF for control
cells to 149.2 ± 29.76 pA/pF for DYRK1A-expressing cells; n =
13 in both conditions, p < 0.05; Figures 5A,E). However, the
phospho-deficient GluN2AS1048A mutant variant did not respond
to the presence of DYRK1A with an alteration in the peak current
density (58.63 ± 10.07 pA/pF for cells expressing GluN2AS1048A
and 79.5 ± 12.51 pA/pF for DYRK1A co-expressing cells, n = 12
and 13, respectively; Figures 5C,E).
To gain insight into the effect of DYRK1A on NMDA chan-
nel gating, we analyzed the opening rate constant of NMDARs.
Agonist-evoked currents were normalized to the same peak
amplitude to compare the time course of decay (Figures 5B,D).
The faster decay of the NMDA current observed in the presence of
DYRK1A indicated a higher rate of channel opening. Indeed, the
statistical analysis showed that the presence of DYRK1A signifi-
cantly increased the opening rate of GluN1/GluN2Awt receptors
(from 2.91 ± 0.62 s−1 in control cells to 6.63 ± 0.89 s−1 in
DYRK1A co-expressing cells, n= 13 in both conditions, p< 0.001;
Figures 5B,F). By contrast, DYRK1A had no effect on the opening
rate of phospho-deficient GluN1/GluN2AS1048A receptors (from
3.85 ± 0.48 s−1 for GluN2AS1048A expressing cells to 4.06 ± 0.44
s−1 for DYRK1A co-expressing cells, n = 12 and 13, respectively;
Figures 5D,F). Together, these data indicate that phosphoryla-
tion of GluN2A at S1048 by DYRK1A not only increases the
NMDA elicited peak current density, which is consistent with
the increased surface expression of GluN1/GluN2A receptors,
but it also affects receptor function by potentiating NMDAR
gating.
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FIGURE 4 | Reduction in the internalization rate of GluN2A in the
presence of DYRK1A. Live transiently co-transfected COS-7 cells were
incubated with an anti-GFP antibody for 30 min at 4◦C. After the rapid
removal of the excess antibody, the cells were placed in the incubator for
additional 30 min at 37◦C to allow the GluN2A-labeled particles to be
internalized. Membrane receptors were then immunolabeled with Alexa647
(shown in gray), whereas the internalized receptors were immunolabeled
with Alexa555 (red particles). Scale bar = 10 µm. Bottom, Histogram
representing the mean ± SEM of the normalized ratio of the internalized
particles and the surface GluN2A receptors (n = 31–115 cells from three
independent experiments, ***p < 0.001, ANOVA).
DISCUSSION
In post-synaptic neurons, the activity and the density of NMDARs
at the membrane are factors that exert an important influence
on neuronal function and synaptic plasticity. Thus, these param-
eters must be finely tuned, which is in part mediated by the
(de)phosphorylation of NMDAR subunits. Much effort has been
dedicated to identify and characterize the role of post-synaptic
density (PSD)-enriched protein kinases that could potentially
phosphorylate NMDARs (reviewed in Chen and Roche, 2007).
Here, we show that DYRK1A interacts with and phosphorylates
NMDAR GluN2A subunits at S1048, a residue within the intra-
cellular C-terminal domain. This phosphorylation provokes an
increase in the surface density of GluN1/GluN2A, which may
be, at least partially due to decreased internalization. More-
over, DYRK1A-mediated phosphorylation of GluN1/GluN2A
modifies the electrophysiological properties of GluN1/GluN2A
heteromers.
Despite their relevance in regulating the physiological activity
of NMDARs, to date only a few protein kinases and phosphatases
have been described that act on NMDARs (Chen and Roche,
2007; Van Dongen et al., 2009). For the GluN2 subunit in
particular, tyrosine kinases (members of the Src family) and a
small number of serine/threonine kinases (calmodulin kinase II,
cyclin-dependent kinase 5, protein kinase A, B and C, and casein
kinase 2) modulate the trafficking, stabilization at the cell surface,
subunit composition or biophysical properties of NMDARs with
a kinase-dependent subunit specificity (Omkumar et al., 1996;
Nakazawa, 2000; Gardoni et al., 2001; Li et al., 2001; Wang et al.,
2003; Chung et al., 2004; Jones and Leonard, 2005; Chen and
Roche, 2009; Zhang et al., 2012; Murphy et al., 2014). These
kinases phosphorylate GluN2 target residues within the large
cytoplasmic tail, mostly the distal part of the primary amino
acid sequence where GluN2 subunits interact with the scaffolding
proteins PSD-95, PSD-97 and SAP-102. In terms of DYRK1A,
and although we cannot completely rule out the existence of
other DYRK1A phosphorylation sites, our results show that S1048,
located within the Cter proximal domain, is the main residue
in GluN2A phosphorylated by DYRK1A. Structural prediction
studies suggest that S1048 and its surrounding amino acids are
unlikely to be located within secondary structures (alpha-helices
and beta-sheets; Ryan et al., 2008), facilitating their easy recog-
nition as a target site. This phosphorylation site, which has not
been described previously, is conserved in different vertebrate
species and it is not present in GluN2B, suggesting subunit
specificity for this phosphorylation event at the S1048 position.
Our results, however, do not allow to completely rule out the
possibility of DYRK1A phosphorylating the GluN2B subunit.
Further studies must be directed to unveil whether DYRK1A
might regulate NDMAR activity by phosphorylating both GluN2
subunits.
The ability of DYRK1A to phosphorylate GluN2A would
require close proximity of the two proteins, achieved either by
their direct physical interaction or their presence in the same
macromolecular protein complex. Our data do not allow us
to distinguish between these possibilities, since the presence of
GluN2A in DYRK1A immunocomplexes could reflect both a
direct interaction with the GluN2A subunit and/or recruitment
to the NMDARs through binding to GluN1 or any other scaffold
protein associated with the heteromeric complexes. Although pre-
liminary results from interaction studies in heterologous expres-
sion systems support a direct interaction between DYRK1A and
NMDARs, further experiments will be necessary to assess the
potential of scaffold protein(s) to mediate DYRK1A-GluN2A
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FIGURE 5 | Dual specificity tyrosine-phosphorylation-regulated kinase
1A increases the NMDA-elicited current amplitude and opening rate.
(A–D) Representative NMDA-elicited currents recorded from HEK-293T
cells expressing HA-GluN1/HA-GluN2A receptors (panels A,B, wild-type
GluN2A; panels C,D, GluN2AS1048A phospho-deficient mutant) in the
presence (right) or absence (left) of GFP-DYRK1A. Whole-cell currents
were elicited by perfusion of 1 mM NMDA with 50 µM glycine, in the
continued presence of the open-channel blocker MK-801 (5 µM). (B,D)
NMDA-evoked currents shown in panels (A) and (C) normalized to the
same peak amplitude. (E) Average peak NMDA-evoked current density in
cells transfected with NMDARs (GluN2Awt or GluN2AS1048A) in the
presence or absence of DYRK1A (*p < 0.05, ANOVA followed by
Bonferroni post hoc test). (F) Average opening rate of heterologously
expressed NMDARs (GluN2Awt or GluN2AS1048A) in the presence or
absence of DYRK1A (***p < 0.001 and *p < 0.05, ANOVA followed by a
Bonferroni post hoc test).
interactions in neurons, as described for other Ser/Thr kinases
regulating NMDARs.
In the mouse brain, the spatio-temporal expression pat-
tern of DYRK1A partially overlaps with GluN2A-containing
NMDARs (Monyer et al., 1994; Martí et al., 2003; Paoletti
et al., 2013), suggesting a potential functional interaction in
the hippocampus, cortex and/or cerebellum. At the subcellular
level, DYRK1A exists as a nuclear and cytoplasmic protein, the
latter composed of three pools: soluble, cytoskeletal-associated
and membrane-bound proteins (Martí et al., 2003; Aranda et al.,
2008; Kaczmarski et al., 2014). This distribution complicates
the identification of the subcellular compartment(s) in which
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DYRK1A interacts with GluN1/GluN2A receptors. Moreover,
the mechanisms controlling DYRK1A intracellular trafficking
remain still elusive. A recent study shed light on the neuronal
activity-dependency of Drosophila Minibrain (Mnb), the fruitfly
DYRK1A homologous gene (Chen et al., 2014). In their study,
Chen and collaborators found that synaptic activity increases
Mnb mobilization to endocytic zones and promoted efficient
synaptic vesicle recycling by dynamically regulating synaptojanin
function during periods of robust synaptic activity. In line with
these findings, NMDARs activity could trigger the recruitment
of DYRK1A to GluN2A subunits, resulting on their phospho-
rylation and the subsequent cellular and electrophysiological
changes.
The DYRK1A-dependent reduction in receptor endocytosis
probably underlies the increase of NMDARs at the cell surface.
Several components of the endocytotic machinery (dynamin
1, amphiphysin 1 and synaptojanin 1), as well as clathrin-
adaptor proteins (AP180), have previously been described as
DYRK1A substrates (Chen-Hwang et al., 2002; Adayev et al.,
2006; Murakami et al., 2012; Chen et al., 2014). DYRK1A-
mediated phosphorylation of these proteins appears to regulate
their protein-protein interactions. Moreover, overexpression of
DYRK1A appears to inhibit endocytosis in transferrin internal-
ization assays (Kim et al., 2010). Therefore, it might be argued
that the effects of DYRK1A on GluN1/GluN2A internalization
result from a direct effect on endocytotic proteins or the regu-
lation of clathrin-coated vesicles formation. Although we do not
exclude the possibility that these DYRK1A activities might con-
tribute to the modulation of GluN1/GluN2A internalization, the
absence of any additional effect on internalization of the phospho-
deficient mutant GluN2AS1048A in combination with DYRK1A,
strongly suggests that GluN1/GluN2A reduced internalization
depends specifically on S1048 phosphorylation of GluN2A by
DYRK1A.
Functionally, DYRK1A phosphorylation of GluN2A at S1048
modifies the biophysical properties of GluN1/GluN2A receptors,
increasing both the peak current density and channel gating. The
DYRK1A-induced increase in the surface density of NMDARs
could be responsible for the increase in peak current density.
Further electrophysiological experiments will be important to
determine whether DYRK1A might also affect GluN1/GluN2A
channel conductance and potentially contribute to the observed
increase of NMDA-elicited currents. In addition, phosphorylation
of GluN2A by DYRK1A favors the opening of GluN1/GluN2A
channels, a parameter that is independent of NMDARs density.
This alteration, together with the increased peak current, might
alter NMDA-induced Ca2+ transients when DYRK1A is over-
expressed. Indeed, a prolonged decay of NMDA-elicited Ca2+
transient was previously observed in synaptosomes and primary
neuronal cultures from TgDyrk1A transgenic mice overexpressing
Dyrk1A. We interpreted this as a genomic effect resulting from
the increased Grin2a transcription and the concomitantly higher
levels of GluN2A in the brains of these animals (Altafaj et al.,
2008). In the light of the current data, we propose that the
alterations observed in TgDyrk1A mice may be strongly influ-
enced by a direct effect of DYRK1A on NMDAR density and
function.
It is noteworthy that DYRK1A has been proposed as a
candidate gene for some of the neuropathological phenotypes
in DS, due to its location within HSA21, the fact that its pro-
tein product is overexpressed in DS individuals, and given that
murine models overexpressing DYRK1A exhibit DS-like phe-
notypic alterations (Guimerà et al., 1996; Altafaj et al., 2001,
2013; Ahn et al., 2006; Dowjat et al., 2007; Guedj et al., 2009;
Laguna et al., 2013). Dual specificity tyrosine-phosphorylation-
regulated kinase 1A gain-of-function models have hippocampal-
dependent cognitive alterations similar to those observed in
Ts65Dn mice, the best characterized trisomic murine model
for DS in which Dyrk1A is overexpressed, among other genes
(reviewed in Sérégaza et al., 2006). Trisomic Ts65Dn mice dis-
play synaptic plasticity alterations that have been attributed
to an excitatory/inhibitory neurotransmitter imbalance. While
there is evidence supporting the role of an excessive inhibi-
tion of GABAergic transmission (Kleschevnikov et al., 2004;
Fernandez and Garner, 2007; Martínez-Cue et al., 2013), the
participation of NMDA-mediated over-activation of hippocam-
pal circuitry in this phenomenon has also been proposed
(Costa et al., 2008; Siddiqui et al., 2008; Scott-McKean and
Costa, 2011). Within a trisomic context, NMDAR dysregu-
lation in DS murine models may be the pathological out-
put of the multiple gene products altered in DS (Siddiqui
et al., 2008). The results presented here suggest a molecular
model in which DYRK1A would be one such protein product.
Dual specificity tyrosine-phosphorylation-regulated kinase 1A
overexpression would increase the phosphorylation of GluN2A-
containing NMDARs, increasing their surface density. The
elevation of membrane NMDAR levels, together with the mod-
ification of their biophysical properties by DYRK1A, would dys-
regulate Ca2+ signaling, contributing to the synaptic alterations
observed in murine models of DS. In summary, we provide the
molecular, cellular and functional evidence that DYRK1A directly
affects NMDARs, supporting the contribution of NMDA-elicited
glutamatergic dysfunction to the excitatory-inhibitory neuro-
transmitter imbalance proposed to drive the pathophysiology of
DS.
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